These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26546255)

  • 21. The choice of prior distribution for a covariance matrix in multivariate meta-analysis: a simulation study.
    Hurtado Rúa SM; Mazumdar M; Strawderman RL
    Stat Med; 2015 Dec; 34(30):4083-104. PubMed ID: 26303671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust joint modeling of longitudinal measurements and time to event data using normal/independent distributions: a Bayesian approach.
    Baghfalaki T; Ganjali M; Berridge D
    Biom J; 2013 Nov; 55(6):844-65. PubMed ID: 23907983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new Bayesian joint model for longitudinal count data with many zeros, intermittent missingness, and dropout with applications to HIV prevention trials.
    Wu J; Chen MH; Schifano ED; Ibrahim JG; Fisher JD
    Stat Med; 2019 Dec; 38(30):5565-5586. PubMed ID: 31691322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous Bayesian inference for linear, nonlinear and semiparametric mixed-effects models with skew-normality and measurement errors in covariates.
    Huang Y; Chen R; Dagne G
    Int J Biostat; 2011; 7(1):8. PubMed ID: 22848189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Jointly Modeling Event Time and Skewed-Longitudinal Data with Missing Response and Mismeasured Covariate for AIDS Studies.
    Huang Y; Yan C; Xing D; Zhang N; Chen H
    J Biopharm Stat; 2015; 25(4):670-94. PubMed ID: 24905593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian joint modeling for partially linear mixed-effects quantile regression of longitudinal and time-to-event data with limit of detection, covariate measurement errors and skewness.
    Zhang H; Huang Y
    J Biopharm Stat; 2021 May; 31(3):295-316. PubMed ID: 33284096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of covariance priors on arm-based Bayesian network meta-analyses with binary outcomes.
    Wang Z; Lin L; Hodges JS; Chu H
    Stat Med; 2020 Sep; 39(22):2883-2900. PubMed ID: 32495349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian variable selection and estimation in semiparametric joint models of multivariate longitudinal and survival data.
    Tang AM; Zhao X; Tang NS
    Biom J; 2017 Jan; 59(1):57-78. PubMed ID: 27667731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian quantile regression-based nonlinear mixed-effects joint models for time-to-event and longitudinal data with multiple features.
    Huang Y; Chen J
    Stat Med; 2016 Dec; 35(30):5666-5685. PubMed ID: 27592848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variational methods for fitting complex Bayesian mixed effects models to health data.
    Lee CY; Wand MP
    Stat Med; 2016 Jan; 35(2):165-88. PubMed ID: 26415742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian nonparametric mixed-effects joint model for longitudinal-competing risks data analysis in presence of multiple data features.
    Lu T
    Stat Methods Med Res; 2017 Oct; 26(5):2407-2423. PubMed ID: 26265770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bayesian approach to joint mixed-effects models with a skew-normal distribution and measurement errors in covariates.
    Huang Y; Dagne G
    Biometrics; 2011 Mar; 67(1):260-9. PubMed ID: 20486924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Dependence Structures for Response Times in a Bayesian Framework.
    Klotzke K; Fox JP
    Psychometrika; 2019 Sep; 84(3):649-672. PubMed ID: 31098935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian variable selection in linear quantile mixed models for longitudinal data with application to macular degeneration.
    Ji Y; Shi H
    PLoS One; 2020; 15(10):e0241197. PubMed ID: 33104698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian semiparametric joint modeling of a count outcome and inconveniently timed longitudinal predictors.
    Lim W; Pennell ML; Naughton MJ; Paskett ED
    Stat Methods Med Res; 2023 May; 32(5):853-867. PubMed ID: 36855822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian model selection for generalized linear mixed models.
    Xu S; Ferreira MAR; Porter EM; Franck CT
    Biometrics; 2023 Dec; 79(4):3266-3278. PubMed ID: 37365985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian random effects selection in mixed accelerated failure time model for interval-censored data.
    Harun N; Cai B
    Stat Med; 2014 Mar; 33(6):971-84. PubMed ID: 24123191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian inference of networks across multiple sample groups and data types.
    Shaddox E; Peterson CB; Stingo FC; Hanania NA; Cruickshank-Quinn C; Kechris K; Bowler R; Vannucci M
    Biostatistics; 2020 Jul; 21(3):561-576. PubMed ID: 30590505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint two-part Tobit models for longitudinal and time-to-event data.
    Dagne GA
    Stat Med; 2017 Nov; 36(26):4214-4229. PubMed ID: 28795414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.